| （単位：千ドル） | 1Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 1Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | - | - | - | - | - | 3,000 | - |
| 研究開発費 | - | 22,721 | 22,821 | 21,310 | 22,889 | 21,834 | 24,966 | 26,261 | 27,409 | 29,509 | 29,457 | 28,816 |
| 営業費用 | - | 30,836 | 30,288 | 29,461 | 30,406 | 29,115 | 32,398 | 33,385 | 34,343 | 37,164 | 37,376 | 34,606 |
| 営業利益 | - | -30,836 | -30,288 | -29,461 | -30,406 | -29,115 | -32,398 | -33,385 | -34,343 | -37,164 | -34,376 | -34,606 |
| 営業利益率 (%) | - | - | - | - | - | - | - | - | - | - | - | |
| 純利益 | -21,300 | -30,687 | -29,465 | -27,374 | -29,958 | -27,718 | -30,431 | -30,608 | -31,431 | -34,740 | -32,271 | -32,085 |
| 純利益率（％） | - | - | - | - | - | - | - | - | - | - | - | |
| 一株あたり利益 | - | - | - | -0.58 | -0.63 | -0.58 | -0.54 | -0.45 | -0.42 | -0.46 | -0.43 | -0.42 |
| 希薄化後一株あたり利益 | - | - | - | -0.58 | -0.63 | -0.58 | -0.54 | -0.45 | -0.42 | -0.46 | -0.43 | -0.42 |
| EBITDA | - | - | - | - | - | - | - | - |